CD8A and vitiligo: More commonly used vitiligo mouse models rely on transgenic technology (Eby et al. 2014; Gregg et al. 2010; Miao et al. 2018; Mosenson et al. 2012) and adoptive transfer (Harris et al. 2012) of melanocyte antigen-recognizing transgenic CD8 + T cells.